Interactions between CKD and MetS and the Development of CVD.

Document Type


Publication Date



This article has been peer reviewed. It was published in: Cardiology research and practice


The published version is available at DOI: 10.4061/2011/878065. Copyright © Hindawi.


Metabolic syndrome (MetS) consists of a combination of metabolic disorders, including increased abdominal circumference, hyperglycemia, elevated blood pressure, and lipid disorders. MetS is now widely accepted as a crucial risk factor for the development of cardiovascular disease (CVD) and mortality. In addition, persistent proteinuria indicating chronic kidney disease (CKD) is well known as a powerful risk factor for the progression of end-stage renal disease and CVD. In recent years, patients with CKD and MetS appear to be increasing along with increasing incidence of CVD in industrial countries.